Trademark: 87771505
Word
NOVAGO PROMOBILITY THERAPEUTICS
Status
Registered
Status Code
700
Status Date
Tuesday, January 28, 2020
Serial Number
87771505
Registration Number
5970084
Registration Date
Tuesday, January 28, 2020
Mark Type
3000
Filing Date
Friday, January 26, 2018
Published for Opposition
Tuesday, November 12, 2019

Trademark Owner History
NovaGo Therapeutics AG - Original Registrant

Classifications
5 Pharmaceutical preparations, namely, for the regenerative treatment of disorders affecting human beings, including, but not limited to, central nervous system, eye, skin and other disorders; veterinary preparations, namely, for the regenerative treatment of disorders, including, but not limited to, central nervous system, eye, skin and other; preparations for immunotherapeutic purposes, namely, for the regenerative treatment of disorders affecting human beings, including, but not limited to, central nervous system, eye, skin and other disorders; products for the removal of tumors, namely preparations for neurodegenerative diseases, namely, but not limited to, traumatic brain injury, spinal cord injury, stroke; immunogens for medical use, namely, for the regenerative treatment of disorders affecting human beings, including, but not limited to, central nervous system, eye, skin and other disorders; vaccines, antibodies, epitopes for pharmaceutical use; peptides for pharmaceutical purposes; sanitary preparations for medical use for the regenerative treatment of disorders affecting human beings, including, but not limited to, central nervous system, eye, skin and other disorders; biological preparations for medical use for the treatment of neurological, ophthalmic, skin disorders; biocides; diagnostic products, namely, for the development of new therapeutic agents; towels for hygiene purposes, namely, sanitary towels; dietetic foods for medical use; dietetic beverages for medical use; protein antibodies for medical purposes, namely, for the regenerative treatment of disorders, including, but not limited to, central nervous system, eye, skin and other disorders
1 Chemical products, namely, for the regenerative treatment of disorders affecting human beings, including but not limited to, central nervous system, eye, skin and other disorders; chemical preparations for industrial purposes; chemical preparations for scientific use other than for medical or veterinary use; chemical preparations for photography; biological materials other than for medical or veterinary purposes, namely, biological monoclonal antibodies and formulations for human therapeutic use; biological preparations for use in industry and science; peptides for chemical products and foodstuffs in the nature of biological monoclonal antibodies and formulations for human therapeutic use; polypeptides; antibodies and proteins for scientific use
44 Medical services; medical services in the field of immunity; provision of medical information; medical examinations, namely, assessments used for clinical research purposes ; dispensing of pharmaceuticals; nutritional and dietary consultancy; consultancy and provision of information in the field of sanitary care; veterinary assistance in the nature of veterinary services, namely, assessments and procedures that leads to novel pharmaceutical products; beauty salon services; care services for animals, namely for the regenerative treatment of veterinary trauma disorders; hygienic care; consultancy and provision of information relating to the operation, preparation, administration and dosage of pharmaceutical preparations
42 Monitoring of degenerative and traumatic disorders affecting human beings for quality control purposes; Research in the field of regenerative treatment of degenerative or traumatic human disorders; medical research in the field of sanitary care; computer software design, computer programming; design and development of computer hardware; software development; consultancy and provision of information relating to quality control of pharmaceutical preparations, namely, preparations for regenerative treatment of human disorders; software maintenance
The mark consists of the wording "NOVAGO" in green font above the wording "PROMOBILITY THERAPEUTICS" in black font. To the right of the wording is a stylized image comprised of a design of four gray lines
The colors green, black, and gray are claimed as a feature of the mark
"PROMOBILITY THERAPEUTICS"

Trademark Events
Nov 10, 2023
Teas Change Of Correspondence Received
Nov 10, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 10, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 21, 2021
Teas Change Of Correspondence Received
Jul 21, 2021
Teas Change Of Domestic Representatives Address
Jul 21, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 21, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 28, 2020
Registered-Principal Register
Nov 12, 2019
Official Gazette Publication Confirmation E-Mailed
Nov 12, 2019
Published For Opposition
Oct 23, 2019
Notification Of Notice Of Publication E-Mailed
Oct 9, 2019
Law Office Publication Review Completed
Oct 7, 2019
Approved For Pub - Principal Register
Sep 16, 2019
Teas/Email Correspondence Entered
Sep 13, 2019
Correspondence Received In Law Office
Sep 13, 2019
Teas Response To Office Action Received
Aug 27, 2019
Notification Of Non-Final Action E-Mailed
Aug 27, 2019
Non-Final Action E-Mailed
Aug 27, 2019
Non-Final Action Written
Aug 5, 2019
Previous Allowance Count Withdrawn
Jul 16, 2019
Withdrawn From Pub - Og Review Query
Jul 3, 2019
Approved For Pub - Principal Register
Jul 3, 2019
Examiner's Amendment Entered
Jul 3, 2019
Notification Of Examiners Amendment E-Mailed
Jul 3, 2019
Examiners Amendment E-Mailed
Jul 3, 2019
Examiners Amendment -Written
Jul 2, 2019
Notification Of Non-Final Action E-Mailed
Jul 2, 2019
Non-Final Action E-Mailed
Jul 2, 2019
Non-Final Action Written
Jun 10, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 10, 2019
Teas Change Of Owner Address Received
Jun 10, 2019
Teas/Email Correspondence Entered
Jun 10, 2019
Correspondence Received In Law Office
Jun 10, 2019
Teas Response To Office Action Received
Jan 10, 2019
Notification Of Priority Action E-Mailed
Jan 10, 2019
Priority Action E-Mailed
Jan 10, 2019
Priority Action Written
Dec 13, 2018
Teas/Email Correspondence Entered
Dec 13, 2018
Correspondence Received In Law Office
Dec 13, 2018
Assigned To Lie
Dec 6, 2018
Teas Response To Suspension Inquiry Received
Nov 29, 2018
Notification Of Letter Of Suspension E-Mailed
Nov 29, 2018
Letter Of Suspension E-Mailed
Nov 29, 2018
Suspension Letter Written
Nov 8, 2018
Teas/Email Correspondence Entered
Nov 8, 2018
Correspondence Received In Law Office
Nov 8, 2018
Teas Response To Office Action Received
May 14, 2018
Notification Of Non-Final Action E-Mailed
May 14, 2018
Non-Final Action E-Mailed
May 14, 2018
Non-Final Action Written
May 9, 2018
Assigned To Examiner
Feb 8, 2018
Notice Of Design Search Code E-Mailed
Feb 7, 2018
New Application Office Supplied Data Entered
Jan 30, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24